WideMed

Creating Morpheus - Sleep analysis system.

Morpheus is a comprehensive sleep analysis platform that enables the upload of sleep studies for detailed evaluation. It facilitates the identification of sleep-related pathologies such as sleep apnea, snoring, and other disorders, as well as the detection of sleep stages. Based on the results, healthcare professionals can prescribe appropriate, targeted treatments.

I came to WideMed as .NET senior developer in 2008. In 2010 I promoted to be the Software development Team Lead, responsible for backend and frontend development. Eventually ending up as a dev group leader, responsible for The whole process, including QA and algorithms integration.

Tech stack: .NET 3.5

Customers:
- SleepMed
- GE Healthcare

Prioritizing customer needs over beauty of technical solutions:

When I became Dev Team Lead at WideMed, the company’s main product was built on .NET 1.1 — a version that had already become obsolete. The engineering team requested a full migration to .NET 3.5. From a purely technical standpoint, a complete rewrite made sense: the versions were incompatible, and upgrading everything at once would have been the cleanest approach. However, this would have taken 4–6 months of development, integration, and QA, with no immediate value for customers — and with significant production risks due to the scale of change.

I proposed an alternative: splitting the upgrade into four incremental stages. This approach was more complex for the team and required careful coordination, but it allowed us to maintain product stability and continue delivering new features during the transition. In the first stage, we rebuilt the major client application using WPF and added WCF capabilities on the backend, even though the architecture wasn’t ideal. This let us introduce thin clients and quickly respond to user requests.

The transition went smoothly. The customer experienced no disruption — in fact, they received new features during the process. Our team also gained hands-on experience with newer technologies, which helped in later phases.

Even now, more than a decade after I left WideMed, I’m still in touch with the CEO of their main customer. He continues to recommend me — and I consider that one of the clearest indicators of long-term success.